- £4.14bn
- £4.90bn
- $2.88bn
- 72
- 51
- 71
- 74
REG - Hikma Pharmaceutical - Total Voting Rights
AnnouncementREG - Hikma Pharmaceutical - Director Declaration
AnnouncementREG - Hikma Pharmaceutical - Hikma acquires Xellia’s assets
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Result of AGM
AnnouncementREG - Hikma Pharmaceutical - Trading Statement
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Hikma appoints new President of Generics business
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Block listing Interim Review
AnnouncementREG - Hikma Pharmaceutical - Annual Financial Report and Notice of AGM
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights
AnnouncementREG - Hikma Pharmaceutical - Final Results
AnnouncementREG - Hikma Pharmaceutical - Notice of Results
AnnouncementREG - Hikma Pharmaceutical - Agreement in Principle for US Opioid Settlement
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights
Announcement